1. Signaling Pathways
  2. Apoptosis
  3. PKD
  4. PKD Isoform
  5. PKD Inhibitor

PKD Inhibitor

PKD Inhibitors (5):

Cat. No. Product Name Effect Purity
  • HY-RS00002
    Pkd1 Mouse Pre-designed siRNA Set A
    Inhibitor

    Pkd1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Pkd1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

  • HY-131962
    PKD-IN-1
    Inhibitor
    PKD-IN-1 (compound 32), an aminoethylamino-aryl (AEAA) compound, acts as PKD-1 inhibitor. PKD-IN-1 can be used for protein kinase D (PKD)-mediated diseases research.
  • HY-RS00004
    Pkd1 Rat Pre-designed siRNA Set A
    Inhibitor

    Pkd1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Pkd1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

  • HY-RS00003
    PKD1 Human Pre-designed siRNA Set A
    Inhibitor

    PKD1 Human Pre-designed siRNA Set A contains three designed siRNAs for PKD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

  • HY-112547
    CRT5
    Inhibitor
    CRT5, a pyrazine benzamide, is a potent and selective inhibitor for all three isoforms of PKD in endothelial cells treated with VEGF (IC50s = 1, 2, and 1.5 nM for PKD1, PKD2, and PKD3, respectively). CRT5 decreases VEGF-induced endothelial migration, proliferation and tubulogenesis.